[ad_1]
- Last week, Pfizer and BioNTech filed for emergency clearance of their coronavirus vaccine with the Food and Drug Administration.
- Once a vaccine is licensed, the CDC Advisory Committee on Immunization Practices (ACIP) will review the vaccine information and vote on whether to “recommend the vaccine and, if so, who should receive it.” “.
- Dr. Celine Gounder, a member of Joe Biden’s COVID-19 advisory board, told CNN on Friday that Biden “is leaving public health experts and scientists to determine how best to allocate the supply first. limited “.
- Visit the Business Insider homepage for more stories.
Dr. Celine Gounder, a member of Joe Biden’s COVID-19 advisory board, told CNN on Friday that public health experts and scientists will decide who among the priority groups gets it first when a limited amount of vaccine becomes available .
“This is where it gets a little more political and, frankly, this is where the president-elect leaves it to public health experts and scientists to determine how best to allocate the supply first. limited, “Gounder told CNN.
Last week, Pfizer and BioNTech filed for emergency clearance of their coronavirus vaccine with the Food and Drug Administration. Pfizer announced that its vaccine had a 95% effectiveness rate in its end-stage clinical trials.
Pfizer has applied for emergency clearance and Moderna, which also reported a 95% effectiveness rate, is expected to do the same by the end of the month, Business Insider’s Aria Bendix reported.
Once a vaccine is licensed, the CDC Advisory Committee on Immunization Practices (ACIP) will review the vaccine information and vote on whether to “recommend the vaccine and, if so, who should receive it.” », According to the committee.
According to ACIP, health workers, essential workers, people at high risk and people 65 years of age or older are the four groups the committee recommends “maybe” to get vaccinated early if the offer is limited.
Public health experts have suggested a variety of frameworks for determining who should get the vaccine first.
According to a report by public health experts from Johns Hopkins University based on data available in August, “those most essential to supporting the ongoing COVID-19 response,” “those most at risk for disease and death, and their caregivers ”, and“ those most essential to maintaining basic societal functions ”are the recommended group of people for priority access to the vaccine.
[ad_2]
Source link